National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings, 18854-18855 [2015-07983]
Download as PDF
<![CDATA[
18854
Federal Register / Vol. 80, No. 67 / Wednesday, April 8, 2015 / Notices
behavior after notification by the blood
center. This will be accomplished using
a new audio computer-assisted
structured interview (ACASI) (See
Attachment 1, Brazil HIV Follow up
ACASI Survey). The third aim will
consist of asking HIV-positive blood
donors about ways to improve the
disclosure of HIV risks during donor
eligibility assessment to better
understand the motivating factors that
drive higher risk persons to donate
blood.
Because our study will build off the
routine blood donor procedures in four
large blood banks in Brazil, it may lead
to more informed conversations around
and possible changes in donor
screening, notification and counseling
policies in Latin America. Results of
these three aims may also help to better
integrate blood centers within the
context of broader HIV testing,
counseling and treatment sites in Brazil.
Similarly, in the US little is known
about donor behavior after notification
In addition to the traditional route of
scientific dissemination through peer
reviewed scientific publication,
previous REDS and REDS–II study data
were the subject of numerous requested
presentations by Federal and nonFederal agencies, including the FDA
Blood Products Advisory Committee,
the HHS Advisory committee on Blood
Safety and Availability, the AABB
Transfusion-Transmitted Diseases
Committee, and the Americas Blood
Centers (ABC). We anticipate similar
requests for results generated from this
study. Data collected in this proposed
HIV Notification study of donors will be
of practical use to the blood banking
and infectious disease communities in
the U.S. and internationally.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
229.
of testing results by blood centers. The
results from this study can be used to
develop insights and hypotheses
focused on developing improved
strategies for notification and
counseling of HIV-positive (or hepatitis
C or B-positive) donors in the U.S.
This proposed study’s findings will
also yield insights into improved
methods for donor self-selection and
qualification post donation, which will
serve to decrease the frequency of
higher-risk persons acting as donors.
Our findings on improved methods for
Brazilian donor notification and linkage
to health care services may also be
applicable to developed countries,
including the U.S. Results of the Brazil
Notification Study will identify how to
improve notification and counseling
strategies that increase the number of
HIV-positive donors seeking prompt
medical care. This might ultimately
boost strategies to prevent secondary
HIV transmission and reduce the risk of
transfusion-transmission.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Type of
respondent
ACASI Questionnaire—Informed Consent ..............
ACASI Questionnaire ...............................................
Adults ........................
Adults ........................
Dated: April 2, 2015.
Lynn Susulske,
NHLBI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 2015–07980 Filed 4–7–15; 8:45 am]
<FNP>
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
asabaliauskas on DSK5VPTVN1PROD with NOTICES
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of meetings of the National
Diabetes and Digestive and Kidney
Diseases Advisory Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
VerDate Sep<11>2014
17:55 Apr 07, 2015
Jkt 235001
Number of
respondents
275
275
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council.
Date: May 13, 2015.
Open: 8:30 a.m. to 12:00 p.m.
Agenda: To present the Director’s Report
and other scientific presentations.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: 4:15 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
1
1
Average
burden per
response
10/60
40/60
Estimated
total annual
burden hours
requested
46
183
Room 715, MSC 5452, Bethesda, MD 20892,
(301) 594–8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council; Kidney, Urologic and Hematologic
Diseases Subcommittee.
Date: May 13, 2015.
Open: 1:00 p.m. to 2:00 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 7, Bethesda, MD 20892.
Closed: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 7, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, MSC 5452, Bethesda, MD 20892,
(301) 594–8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council; Digestive Diseases and Nutrition
Subcommittee.
Date: May 13, 2015
Open: 1:00 p.m. to 2:30 p.m.
Agenda: To review the Division’s scientific
and planning activities.
E:\FR\FM\08APN1.SGM
08APN1
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 67 / Wednesday, April 8, 2015 / Notices
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Closed: 2:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, MSC 5452, Bethesda, MD 20892,
(301) 594–8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council; Diabetes, Endocrinology and
Metabolic Diseases Subcommittee.
Date: May 13, 2015.
Open: 2:00 p.m. to 4:00 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, MSC 5452, Bethesda, MD 20892,
(301) 594–8843, stanfibr@niddk.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
www.niddk.nih.gov/fund/divisions/DEA/
Council/coundesc.htm, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: April 2, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–07983 Filed 4–7–15; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:55 Apr 07, 2015
Jkt 235001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases;. Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; LRP Fiscal Year
2015 Applications.
Date: April 24, 2015.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: John F. Connaughton,
Ph.D., Chief, Training and Mentored
Research Section, REVIEW BRANCH, DEA,
NIDDK, NATIONAL INSTITUTES OF
HEALTH, ROOM 753, 6707 DEMOCRACY
BOULEVARD, BETHESDA, MD 20892–5452,
(301) 594–7797,
connaughtonj@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; PAR–14–301:
NIDDK Central Repositories Non-Renewable
Samples Access (X01).
Date: May 26, 2015.
Time: 2:00 p.m. to 4:00 p.m.
AGENDA: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: NAJMA BEGUM, PH.D.,
SCIENTIFIC REVIEW OFFICER, REVIEW
BRANCH, DEA, NIDDK, NATIONAL
INSTITUTES OF HEALTH, ROOM 749, 6707
DEMOCRACY BOULEVARD, BETHESDA,
MD 20892–5452, (301) 594–8894,
begumn@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Biomarkers for
Diabetes and Kidney Diseases using
Biosamples from NIDDK Repository (R01–
PAR–13–228).
Date: May 28, 2015.
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
18855
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: NAJMA BEGUM, PH.D.,
SCIENTIFIC REVIEW OFFICER, REVIEW
BRANCH, DEA, NIDDK, NATIONAL
INSTITUTES OF HEALTH, ROOM 749, 6707
DEMOCRACY BOULEVARD, BETHESDA,
MD 20892–5452, (301) 594–8894,
begumn@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: April 2, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–08167 Filed 4–7–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No.—USCG–2015–0201]
Chemical Transportation Advisory
Committee; Vacancies
Coast Guard, DHS
Request for applications.
AGENCY:
ACTION:
The Coast Guard seeks
applications for membership on the
Chemical Transportation Advisory
Committee. The Chemical
Transportation Advisory Committee
provides advice and makes
recommendations on matters relating to
the safe and secure marine
transportation of hazardous materials
activities insofar as they relate to
matters within the United States Coast
Guard’s jurisdiction.
DATES: Completed applications should
reach the Coast Guard on or before June
8, 2015.
ADDRESSES: Applicants should send a
cover letter expressing interest in an
appointment to the Chemical
Transportation Advisory Committee that
also identifies which membership
category the applicant is applying
under, along with a resume detailing the
applicant’s experience via one of the
following methods:
• By Email: cristina.e.nelson@
uscg.mil.
• By Fax: (202) 372–8380.
• By Mail: Lieutenant Cristina
Nelson, Alternate Designated Federal
SUMMARY:
E:\FR\FM\08APN1.SGM
08APN1
]]>Agencies
[Federal Register Volume 80, Number 67 (Wednesday, April 8, 2015)]
[Notices]
[Pages 18854-18855]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-07983]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of meetings of the
National Diabetes and Digestive and Kidney Diseases Advisory Council.
The meetings will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council.
Date: May 13, 2015.
Open: 8:30 a.m. to 12:00 p.m.
Agenda: To present the Director's Report and other scientific
presentations.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Closed: 4:15 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, Ph.D., Director, Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd., Room 715, MSC 5452,
Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council; Kidney, Urologic and Hematologic Diseases
Subcommittee.
Date: May 13, 2015.
Open: 1:00 p.m. to 2:00 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 7, Bethesda, MD 20892.
Closed: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 7, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, Ph.D., Director, Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd., Room 715, MSC 5452,
Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council; Digestive Diseases and Nutrition
Subcommittee.
Date: May 13, 2015
Open: 1:00 p.m. to 2:30 p.m.
Agenda: To review the Division's scientific and planning
activities.
[[Page 18855]]
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 6, Bethesda, MD 20892.
Closed: 2:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 6, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, Ph.D., Director, Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd., Room 715, MSC 5452,
Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council; Diabetes, Endocrinology and Metabolic
Diseases Subcommittee.
Date: May 13, 2015.
Open: 2:00 p.m. to 4:00 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Closed: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, Ph.D., Director, Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd., Room 715, MSC 5452,
Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: www.niddk.nih.gov/fund/divisions/DEA/Council/coundesc.htm,
where an agenda and any additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: April 2, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-07983 Filed 4-7-15; 8:45 am]
BILLING CODE 4140-01-P
